Table 3. Demographic, laboratory characteristics of KD patients during diagnosis in the group with and without CAL.
CAL− | CAL+ | p value | ||
---|---|---|---|---|
Sex | Male | 2,397 (51.9) | 336 (62.7) | <0.001 |
Female | 1,862 (40.3) | 146 (27.2) | ||
Not identified | 356 (7.7) | 54 (10.1) | ||
Age (months) | 31.78±24.29 | 36.57±22.61 | <0.001 | |
Duration of fever before IVIG treatment | 6.62±3.85 | 6.38±3.46 | 0.174 | |
PMN (%) | 62.97±31.50 | 65.64±33.48 | 0.067 | |
Albumin (g/dL) | 4.11±8.54 | 4.29±7.87 | 0.642 | |
Total bilirubin (g/dL) | 0.77±4.77 | 1.29±8.55 | 0.038 | |
AST (IU/L) | 83.00±150.83 | 80.05±142.60 | 0.668 | |
ALT (IU/L) | 92.22±148.55 | 85.62±131.69 | 0.328 | |
CRP (mg/dL) | 7.86±9.42 | 9.79±14.25 | 0.002 | |
NT-proBNP (pg/dL) | 984.74±2,428.99 | 1,179.93±2,453.97 | 0.079 |
Values are presented as number (%) or mean±standard deviation.
ALT = alanine aminotransferase; AST = aspartate aminotransferase; CAL = coronary artery lesion; CRP = C-reactive protein; IVIG = intravenous immunoglobulin; KD = Kawasaki disease; NT-proBNP = N-terminal-pro-brain natriuretic peptide; PMN = polymorphonuclear neutrophil.